Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Change in range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle |
Range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in maximal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle |
Maximal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in minimal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle |
Minimal value of range of motion of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in angular velocity of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle |
Angular velocity of pelvis, joints of lower limb and foot in coronal, transversal and frontal plane during stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in walking velocity |
Walking velocity will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in walking cadence |
Walking cadence will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in step length during walking |
Step length will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in duration of stance phase of the gait cycle |
Duration of stance phase of the gait cycle will be measured by the Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in maximum value of the vertical component of ground reaction force during walking |
Maximum value of the vertical component of ground reaction force will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in minimum value of the vertical component of ground reaction force during walking |
Minimum value of the vertical component of ground reaction force will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in impulse of the vertical component of ground reaction force during walking |
Impulse of the vertical component of ground reaction force will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in lower limbs joints moments during walking |
Lower limbs joints moments will be measured by two force plates Kistler (Kistler, Winterhur, Switzerland) synchronized with Vicon Vantage V5 (Vicon Motion System, London, Great Britain). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in peak plantar pressure at anatomical regions of the foot sole during walking |
Peak plantar pressure at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in contact time at anatomical regions of the foot sole during walking |
Contact time at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in contact area at anatomical regions of the foot sole during walking. |
Contact area at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in pressure-time integral at anatomical regions of the foot sole during walking |
Pressure-time integral at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in maximum force at anatomical regions of the foot sole during walking |
Maximum force at anatomical regions of the foot sole during walking will be measured by pressure plate 2M footscan® (RSscan International NV, Paal, Belgium). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in foot length |
Foot length will be measured by RSS 3D Scanner (RSScan International NV, Paal, Belgium). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in foot width |
Foot width will be measured by RSS 3D Scanner (RSScan International NV, Paal, Belgium). |
at baseline and at the end of 6 months intervention |
|
Primary |
Change in tactile-foot perception |
Tactile-foot perception will be measured by Baseline Tactile Monofilaments (Fabrication Enterprises, White Plains, NY, USA). |
at baseline and at the end of 6 months intervention |
|